Randomized Controlled Trial
doi: 10.1080/00207450500341506.
Dhea supplementation and cognition in postmenopausal women
Affiliations
- PMID: 16393880
- DOI: 10.1080/00207450500341506
Item in Clipboard
Randomized Controlled Trial
Dhea supplementation and cognition in postmenopausal women
Int J Neurosci.
2006 Feb.
Abstract
Previous work has suggested that DHEA supplementation may have adverse cognitive effects in elderly women. This article analyzed 24-h measurements of DHEA, DHEAS, and cortisol to determine if cognitive decrease with treatment is mediated by DHEA's impact on endogenous cortisol. It was found that DHEA administration increased cortisol at several hours during the day. In the treatment group, cortisol was positively associated with cognition at study completion. An increase in negative associations between DHEA(S) levels and cognition was found at completion. Increased cortisol does not explain the cognitive deficits associated with DHEA, suggesting a direct negative effect of exogenous DHEA on cognition.
Similar articles
-
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.Gynecol Endocrinol. 2006 Nov;22(11):627-35. doi: 10.1080/09513590601024681. Gynecol Endocrinol. 2006. PMID: 17145649 Clinical Trial.
-
Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women.Horm Behav. 2004 Feb;45(2):144-55. doi: 10.1016/j.yhbeh.2003.09.008. Horm Behav. 2004. PMID: 15019802 Clinical Trial.
-
Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.Fertil Steril. 2004 Mar;81(3):595-604. doi: 10.1016/j.fertnstert.2003.07.035. Fertil Steril. 2004. PMID: 15037408 Clinical Trial.
-
Dehydroepiandrosterone sulfate and postmenopausal women.Curr Opin Endocrinol Diabetes Obes. 2011 Jun;18(3):171-6. doi: 10.1097/MED.0b013e3283461818. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21478748 Review.
-
Dehydroepiandrosterone administration in humans: evidence based?Neth J Med. 2005 Sep;63(8):300-4. Neth J Med. 2005. PMID: 16186639 Review.
Cited by
-
Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition.J Clin Endocrinol Metab. 2009 Aug;94(8):2945-51. doi: 10.1210/jc.2009-0386. Epub 2009 May 26. J Clin Endocrinol Metab. 2009. PMID: 19470626 Free PMC article.
-
Dehydroepiandrosterone and age-related cognitive decline.Age (Dordr). 2010 Mar;32(1):61-7. doi: 10.1007/s11357-009-9113-4. Epub 2009 Aug 27. Age (Dordr). 2010. PMID: 19711196 Free PMC article. Review.
-
Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial.J Am Geriatr Soc. 2008 Jul;56(7):1292-8. doi: 10.1111/j.1532-5415.2008.01768.x. Epub 2008 May 14. J Am Geriatr Soc. 2008. PMID: 18482290 Free PMC article. Clinical Trial.
-
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD011066. doi: 10.1002/14651858.CD011066.pub2. Cochrane Database Syst Rev. 2015. PMID: 25879093 Free PMC article.
-
Dehydroepiandrosterone, Its Sulfate and Cognitive Functions.Clin Pract Epidemiol Ment Health. 2016 Apr 29;12:24-37. doi: 10.2174/1745017901612010024. eCollection 2016. Clin Pract Epidemiol Ment Health. 2016. PMID: 27346998 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
